Budesonide APOLLO
|
|
- Dustin Wilson
- 6 years ago
- Views:
Transcription
1 Budesonide APOLLO Budesonide APOLLO Budesonide CAS Number : Molecular Weight : g/mol Molecular Formula : C25H34O6 Systematic (IUPAC) : (1S,2S,4R,8S,9S,11S,12S,13R)- 11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6- propyl-5,7- dioxapentacyclo[ ^{2,9}.0^{4,8}.0^{13,18}]icos a-14,17-dien-16-one DRUG DESCRIPTION
2 Budesonide CAS number Budesonide is a man-made glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone which is produced in the adrenal glands. It is used for treating asthma by inhalation. Glucocorticoid steroids such as cortisol or budesonide have potent anti-inflammatory actions that reduces inflammation and hyper-reactivity (spasm) of the airways caused by asthma. When used as an inhaler, the budesonide goes directly to the inner lining of the inflamed airways to exert its effects. Only 39% of an inhaled dose of budesonide is absorbed into the body, and the absorbed budesonide contributes little to the effects on the airways Budesonide is provided as the mixture of two epimers (22R and 22S).Budesonide is a white to off-white, odorless powder that is practically insoluble in water and in heptane, sparingly soluble in ethanol, and freely soluble in chloroform.its partition coefficient between octanol and water at ph 5 is 1.6 x 10.3 USES The budesonide inhaler is used for the control of asthma in persons requiring continuous, prolonged treatment. Such patients may include those with frequent asthmatic episodes requiring bronchodilators. Budesonide is used to treat Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever). Budesonide is in a class of medications called corticosteroids. It works by decreasing inflammation (swelling) in the digestive tract of people who have Crohn's disease.
3 DOSAGE Budesonide comes as a capsule to take by mouth. It is usually taken once a day in the morning. Take budesonide at around the same time every day. Your doctor will tell you how long to take budesonide. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take budesonide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Swallow the capsules whole; do not split, chew, or crush them. If you are unable to swallow the capsules whole, talk to your doctor. Budesonide may help control your symptoms, but it will not cure your condition. Your doctor will watch you carefully to see how well budesonide works for you. If your symptoms are controlled, your doctor may decrease your dose of budesonide. After your symptoms have been controlled for 3 months, your doctor may slowly decrease your dose and then stop treating you with this medication. It is important to tell your doctor how you are feeling during your treatment. Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient. SIDE EFFECTS Generic Budesonide is a Corticosteroid used for the treatment of mild-to-moderately-active Crohn's disease involving the ileum (the second half of the small intestine) and/or ascending colon (the beginning of the large intestine). Like other medicines, Generic Budesonide can cause some side effects. If they occur, the side effects of
4 Generic Budesonide are most likely to be minor and temporary. However, some may be serious and need medical attention and may require the individual to inform the doctor or visit the nearest hospital. It is pertinent to note that side effects of Generic Budesonide cannot be anticipated. If any side effects of Generic Budesonide develop or change in intensity, the doctor should be informed as soon as possible. Some of the most serious Generic Budesonide side Effects include bloody or black, tarry stools, confusion, excitement, restlessness, a false sense of well being, eye pain, decreased or blurred vision, fever, sore throat, sneezing, and cough. This is not a complete list of all Side effects. Do concur with your doctor and follow his directions completely when you are taking Generic Budesonide. Budesonide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away: * headache * dizziness * runny nose, sneezing, coughing * nausea * indigestion * abdominal pain * gas * vomiting * fatigue * back pain * pain Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately: * itching * skin rash * fever
5 * swelling of face and neck * difficulty breathing * severe headache * changes in vision * acne * bruising Budesonide may cause other side effects. Call your doctor if you have any unusual problems while taking this medication or if your symptoms get worse. PRECAUTIONS Before taking budesonide, * tell your doctor and pharmacist if you are allergic to budesonide, or any other medications. * tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: clarithromycin, erythromycin, ketoconazole, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, and telithromycin. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with budesonide, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. * tell your doctor if you or anyone in your family has had diabetes (high blood sugar) or glaucoma, or if you have tuberculosis, high blood pressure, osteoporosis (a condition in which the bones become thin and weak and break easily), stomach ulcer, cataracts, or liver disease. * tell your doctor if you are pregnant, think you may be pregnant, or plan to become pregnant, or are breast-
6 feeding. If you become pregnant while taking budesonide, call your doctor. * if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking budesonide. * tell your doctor if you have never had chicken pox or measles and you have not been vaccinated against these infections. Stay away from people who are sick, especially people who have chicken pox or measles. If you are exposed to one of these infections or if you develop symptoms of one of these infections, call your doctor right away. You may need treatment to protect you from these infections. PREPARATIONS Pulmicort Turbuhaler 200 mcg: each 200 mcg actuation delivers 160 mcg of budesonide. Pulmicort Respules, 0.25 mg/2ml, 0.5 mg/2ml suspension, and 1 mg/2ml STORAGE Budesonide should be stored at room temperature, C (68-77 F). PRESCRIBED FOR: The budesonide inhaler is used for the control of asthma in persons requiring continuous, prolonged treatment. Such patients may include those with frequent asthmatic episodes requiring bronchodilators, for example, albuterol (Ventolin) or those with asthmatic episodes at night. DOSING Budesonide is used to prevent asthmatic attacks and should not be used to treat an acute attack of asthma.
7 The Turbuhaler is used for individuals six years of age or older. Effects can be seen within 24 hours, but maximum effects may not be seen for 1-2 weeks or longer. Doses vary widely. Adults usually receive 1 to 4 actuations (puffs) twice daily. Children usually receive 1 to 2 puffs twice daily. For those with mild asthma, treatment once daily may be sufficient. Pulmicort Respules are used for individuals 12 months to eight years of age. Effects are seen in 2 to 8 days, but maximum effects may not be seen for up to 4 to 6 weeks. Pulmicort Respules are used with a jet nebulizer. They usually are taken as one or two doses for a total of mg daily. DRUG INTERACTIONS Ketoconazole (Nizoral, Extina, Xolegel, Kuric) increases the concentrations in blood of budesonide, and this may lead to an increase in the side effects of budesonide. No drug interactions have been described with inhaled budesonide. PREGNANCY When given orally to animals, glucocorticoid steroids similar to budesonide have been shown to cause fetal abnormalities. Studies of pregnant women using inhaled budesonide during early pregnancy, however, do not show an increase in the rate of fetal abnormalities. Nevertheless, since these studies cannot exclude the possibility of rare effects on the fetus, inhaled budesonide should be used with caution during pregnancy.
8 NURSING MOTHERS It is not known if budesonide is secreted in breast milk. Other medications similar to budesonide are indeed secreted in breast milk. It is not known whether the small amounts that may appear in breast milk have effects on the infant. Type small molecule Description A glucocorticoid used in the management of asthma, the treatment of various skin disorders, and allergic rhinitis. Categories Anti-inflammatory Agents Bronchodilator Agents Corticosteroids Glucocorticoids Pharmacology Indication For the treatment of mild to moderate active Crohn's disease. Also for the treatment of asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. Pharmacodynamics Budesonide is a synthetic corticosteroid used in Crohn's disease to decrease the symptoms and inflammation associated with the disease, especially at times of flare
9 up. Budesonide has a high topical glucocorticosteroid (GCS) activity and a substantial first pass elimination. The formulation contains granules which are coated to protect dissolution in gastric juice, but which dissolve at ph >5.5, ie, normally when the granules reach the duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the release of the drug into the intestinal lumen in a time-dependent manner. Mechanism of action The exact mechanism of action of budesonide in the treatment of Crohn's disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect. Absorption Absorption is complete following oral administration. Metabolism Following absorption, budesonide is subject to high first pass metabolism (80-90%). In vitro experiments in human liver microsomes demonstrate that budesonide is rapidly and extensively biotransformed, mainly by CYP3A4, to its 2 major metabolites, 6b-hydroxy budesonide and 16a- hydroxy prednisolone. The glucocorticoid activity of these metabolites is negligible (<1/100) in relation to that of the parent compound. Route of elimination Budesonide is excreted in urine and feces in the form of metabolites.
10 Toxicity Single oral doses of 200 and 400 mg/kg were lethal in female and male mice, respectively. The signs of acute toxicity were decreased motor activity, piloerection and generalized edema. apollo asia Division apollo Pharmaceuticals INDIA [P] Ltd asia Division Mr.Vipin Saxena CEO DIRECT: Wireline Purchase HELPDESK: Wireline Sales HELPDESK: Wireless 24x7 HELPDESK: Blackberry Pin : 32E6500D 32E C58 apollo@hotmail.co.in Sales@apollopharma.in Export@apollopharma.in purchase@apollopharma.in
11 Chat: MSN Hotmail:VipinrSaxena Skype NAME:VipinrSaxena Rocketmail:VipinrSaxena Google mail:vipinrsaxena BlackBerry:28415C58 Regd. Office :- 1104, Maker Chamber V, Nariman Point Mumbai, INDIA Pin: Industrial Office D-62, OIC India Oshiwara Industrial Centre, New Link Road, Goregoan West, Mumbai, INDIA Pin: Manufacturing Unit Address: Plot No. 117A, Village: Chamble Near MonaTona Limited.Wada, Maharashtra, PIN : INDIA apollo@hotmail.co.in Sales@apollopharma.in Export@apollopharma.in purchase@apollopharma.in
12
13
14
15
16
Bromhexine apollo
Bromhexine apollo +9191 46 950 950 Bromhexine apollo +9191 46 950 950 Bromhexine CAS Number : 3572-43-8 Molecular Weight : 376.13 g/mol Molecular Formula :C14H20Br2N2 Systematic (IUPAC) : 2,4-dibromo-6-
More informationAtomoxetine Hydrochloride apollo
Atomoxetine Hydrochloride apollo +9191 46 950 950 Atomoxetine Hydrochloride apollo +9191 46 950 950 Atomoxetine Hydrochloride CAS Number : 82248-59-7 Molecular Weight : 291.82 g/mol Molecular Formula :
More informationMagnesium citrate apollo
Magnesium citrate apollo +9191 46 950 950 Magnesium citrate apollo +9191 46 950 950 Magnesium citrate CAS Number : 7779-25-1 Molecular Formula : C6H6MgO7 Molecular Weight : 214.41 g/mol Systematic (IUPAC)
More informationDesmopressin Monoacetate apollo
Desmopressin Monoacetate apollo +919146950950 Desmopressin Monoacetate apollo +919146950950 Desmopressin Monoacetate CAS Number : 62288-83-9 Protein binding : 50% Molecular Weight : 1069.22 g/mol Molecular
More informationVitamin A palmitate apollo
Vitamin A palmitate apollo +9191 46 950 950 Vitamin A palmitate apollo +9191 46 950 950 Vitamin A palmitate CAS Number : 79-81-2 Molecular Weight : 524.96 g/mol Molecular Formula : C36H60O2 Systematic
More informationOxalic Acid apollo Oxalic Acid apollo Oxalic Acid
Oxalic Acid apollo +9191 46 950 950 Oxalic Acid apollo +9191 46 950 950 Oxalic Acid CAS Number : 144-62-7 Molecular Formula : C2H2O4 Molecular Weight : 90.03 g/mol Systematic (IUPAC) : ethanedioic acid
More informationFexofenadine apollo
Fexofenadine apollo +9191 46 950 950 Fexofenadine apollo +9191 46 950 950 Fexofenadine CAS Number : 83799-24-0 Molecular Weight : 501.65 g/mol Molecular Formula : C32H39NO4 Systematic (IUPAC) : 2-(4-{1-hydroxy-4-[4-
More informationBenzylpenicillin apollo Benzylpenicillin apollo Benzylpenicillin
Benzylpenicillin apollo +9191 46 950 950 Benzylpenicillin apollo +9191 46 950 950 Benzylpenicillin CAS Number : 61-33-6 Molecular Weight : 334.4 g/mol Molecular Formula :C16H18N2O4S Systematic (IUPAC)
More informationCyclobenzaprine apollo
Cyclobenzaprine apollo +9191 46 950 950 Cyclobenzaprine apollo +9191 46 950 950 Cyclobenzaprine CAS Number : 303-53-7 Molecular Formula : C20H21N Molecular Weight :275.38 g/mol Systematic (IUPAC) : dimethyl({3-[(2e)-
More informationVildagliptin apollo Vildagliptin apollo Vildagliptin apollo Vildagliptin
Vildagliptin apollo +9191 46 950 950 Vildagliptin apollo +9191 46 950 950 Vildagliptin apollo +9191 46 950 950 Vildagliptin CAS Number : 274901-16-5 Molecular Weight : 303.39 g/mol Molecular Formula :
More informationDexamethasone apollo
Dexamethasone apollo +9191 46 950 950 Dexamethasone apollo +9191 46 950 950 Dexamethasone CAS Number : 50-02-2 Molecular Weight : 392.4611 g/mol Molecular Formula : C22H29FO5 Systematic (IUPAC) : (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-
More informationMagnesium carbonate apollo
Magnesium carbonate apollo +9191 46 950 950 Magnesium carbonate apollo +9191 46 950 950 Magnesium carbonate CAS Number : 546-93-0 Molecular Formula : MgCO3 Molecular Weight : 84.313 g/mol Systematic (IUPAC)
More informationLabetalol apollo
Labetalol apollo +9191 46 950 950 Labetalol apollo +9191 46 950 950 Labetalol CAS Number : 36894-69-6 Molecular Weight : 328.40 g/mol Molecular Formula : C19H24N2O3 Systematic (IUPAC) : 2-hydroxy-5-{1-hydroxy-2-[(4-
More informationSodium valproate apollo Sodium valproate apollo Sodium valproate
Sodium valproate apollo +9191 46 950 950 Sodium valproate apollo +9191 46 950 950 Sodium valproate CAS Number : 1069-66-5 Molecular Formula : C8H15NaO2 Molecular Weight : 166.20 g/mol Systematic (IUPAC)
More informationOndansetron apollo Ondansetron apollo Ondansetron
Ondansetron apollo +9191 46 950 950 Ondansetron apollo +9191 46 950 950 Ondansetron CAS Number : 99614-02-5 Molecular Formula : C18H19N3O Molecular Weight : 293.36 g/mol Systematic (IUPAC) : 9-methyl-3-[(2-methyl-1H-
More informationNitazoxanide apollo
Nitazoxanide apollo +9191 46 950 950 Nitazoxanide apollo +9191 46 950 950 Nitazoxanide CAS Number : 55981-09-4 Molecular Weight : 307.28 g/mol Molecular Formula : C12H9N3O5S Systematic (IUPAC) : 2-[(5-nitro-1,3-thiazol-2-yl)
More informationMiglitol apollo
Miglitol apollo +9191 46 950 950 Miglitol apollo +9191 46 950 950 Miglitol CAS Number : 72432-03-2 Molecular Weight : 207.2243 g/mol Molecular Formula : C8H17NO5 Systematic (IUPAC) : (2R,3R,4R,5S)-1-(2-
More informationCilostazol apollo
Cilostazol apollo +9191 46 950 950 Cilostazol apollo +9191 46 950 950 Cilostazol CAS Number : 73963-72-1 Molecular Weight : 369.46 g/mol Molecular Formula : C20H27N5O2 Systematic (IUPAC) : 6-[4-(1-cyclohexyl-1H-1,2,3,4-
More informationEptifibatide apollo
Eptifibatide apollo +9191 46 950 950 Eptifibatide apollo +9191 46 950 950 Eptifibatide CAS Number : 188627-80-7 Molecular Weight : 831.96 g/mol Molecular Formula : C35H49N11O9S2 Systematic (IUPAC) : N
More informationLansoprazole apollo
Lansoprazole apollo +9191 46 950 950 Lansoprazole apollo +9191 46 950 950 Lansoprazole CAS Number : 103577-45-3 Molecular Weight : 369.361 g/mol Molecular Formula : C16H14F3N3O2S Systematic (IUPAC) : 2-({[3-methyl-4-(2,2,2-
More informationForskolin apollo
Forskolin apollo +9191 46 950 950 Forskolin apollo +9191 46 950 950 Forskolin CAS Number : 64657-11-0 Molecular Formula : C22H34O7 Molecular Weight : 410.50 g/mol Systematic (IUPAC) : (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10btrihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-naphtho[2,1-b]pyran-5-yl
More informationPatient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol. Do not use your ALVESCO Inhalation Aerosol near heat or an open flame.
Note: For Oral Inhalation Only Patient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol Do not use your ALVESCO Inhalation Aerosol near heat or an open flame. Read this Patient Information
More informationEplerenone apollo
Eplerenone apollo +9191 46 950 950 Eplerenone apollo +9191 46 950 950 Eplerenone CAS Number : 107724-20-9 Molecular Formula : C24H30O6 Molecular Weight : 414.49 g/mol Systematic (IUPAC) : methyl (1'R,2R,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-
More informationDextromethorphan apollo
Dextromethorphan apollo +9191 46 950 950 Dextromethorphan apollo +9191 46 950 950 Dextromethorphan CAS Number : 125-71-3 Molecular Formula : C18H25NO Molecular Weight : 271.39 g/mol Systematic (IUPAC)
More informationPackage leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide
Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPatient Information ASMANEX HFA (AZ-ma-neks) (mometasone furoate) Inhalation Aerosol What is ASMANEX HFA?
Patient Information ASMANEX HFA (AZ-ma-neks) (mometasone furoate) Inhalation Aerosol What is ASMANEX HFA? ASMANEX HFA is an inhaled prescription medicine used as maintenance treatment for the prevention
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for
PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If
More informationPackage leaflet: Information for the patient. Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone
Package leaflet: Information for the patient Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone Read all of this leaflet carefully before you start taking this
More informationEntocort. Budesonide 3 mg capsules CONSUMER MEDICINE INFORMATION
Entocort Budesonide 3 mg capsules CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some of the common questions people ask about Entocort. It does not contain all the information
More informationDihydrocodeine hydrogen tartrate apollo
Dihydrocodeine hydrogen tartrate apollo +9191 46 950 950 Dihydrocodeine hydrogen tartrate apollo +9191 46 950 950 Dihydrocodeine hydrogen tartrate CAS Number : 5965-13-9 Molecular Weight : 451.47 g/mol
More informationPATIENT INFORMATION NASONEX [nā-zə-neks] 50 mcg (mometasone furoate monohydrate) Nasal Spray For Intranasal Use Only Read the Patient Information
PATIENT INFORMATION NASONEX [nā-zə-neks] 50 mcg (mometasone furoate monohydrate) Nasal Spray For Intranasal Use Only Read the Patient Information that comes with NASONEX before you start using it and each
More informationPrazosin apollo
Prazosin apollo +9191 46 950 950 Prazosin apollo +9191 46 950 950 Prazosin CAS Number : 19216-56-9 Molecular Formula : C19H21N5O4 Molecular Weight : 383.401 g/mol Systematic (IUPAC) : 2-{4-[(furan-2- yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-
More informationQuestions to ask your Doctor
Questions to ask your Doctor What is my current blood pressure? What are my target blood pressure numbers? What blood pressure medication(s) am I currently taking? How is this drug different from what
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Respules 1 mg/2 ml Nebuliser Suspension budesonide
PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Respules 1 mg/2 ml Nebuliser Suspension budesonide Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may
More informationDonepezil apollo Donepezil apollo Donepezil
Donepezil apollo +9191 46 950 950 Donepezil apollo +9191 46 950 950 Donepezil CAS Number : 120014-06-4 Melting point : 207 ºC Molecular Weight : 379.49 g/mol Molecular Formula : C24H29NO3 Systematic (IUPAC)
More informationPatient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets
Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets Read the Patient Information Leaflet that comes with montelukast sodium before you start taking it and each time you
More informationAmitriptyline apollo Amitriptyline apollo Amitriptyline
Amitriptyline apollo +9191 46 950 950 Amitriptyline apollo +9191 46 950 950 Amitriptyline CAS Number : 50-48-6 Molecular Weight : 277.40 g/mol Molecular Formula : C20H23N Systematic (IUPAC) : dimethyl({3-[(2z)-
More informationEvening Primrose Oil apollo
Evening Primrose Oil apollo +91 91 46 950 950 Evening Primrose Oil apollo +91 91 46 950 950 Evening Primrose Oil CAS Number : 90028-66-3 Molecular Formula : C18H30O2 Systematic (IUPAC) : Oenotherabiennis
More informationCefprozil apollo Cefprozil apollo Cefprozil
Cefprozil apollo +91 91 46 950 950 Cefprozil apollo +91 91 46 950 950 Cefprozil CAS Number : 92665-29-7 Molecular Weight : 389.426 g/mol Molecular Formula : C18H19N3O5S Systematic (IUPAC) : (6R,7R)-7-[(2R)-2-amino-2-(4-
More informationINFORMATION FOR THE CONSUMER IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT
- 1 - INFORMATION FOR THE CONSUMER IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT PULMICORT NEBUAMP (budesonide suspension for inhalation) Before using PULMICORT NEBUAMP, read this leaflet carefully. It contains
More informationFor the Patient: USMAVFIPI
For the Patient: USMAVFIPI Other Names: First-Line Treatment of Unresectable or Metastatic Melanoma Using Ipilimumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced F =
More informationActhar TREATMENT JOURNAL
Acthar TREATMENT JOURNAL Help for patients in the grip of dermatomyositis or polymyositis What is Acthar? Acthar is a prescription medicine used for flares or on a regular basis (maintenance) in people
More informationRABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationInlyta (axitinib) for Kidney Cancer
Inlyta (axitinib) for Kidney Cancer Inlyta is a medication used to treat advanced kidney cancer in adults when one prior drug treatment for this disease has not worked Dosage: 5mg taken twice a day How
More informationFLOMIST Aqueous Nasal Spray (Fluticasone propionate)
Published on: 10 Jul 2014 FLOMIST Aqueous Nasal Spray (Fluticasone propionate) Composition FLOMIST Aqueous Nasal Spray Each spray delivers: Fluticasone Propionate BP...50 mcg Fluticasone Propionate BP...
More informationFOR PATIENTS WITH SYMPTOMS OF SARCOIDOSIS. Treatment Journal. H.P. Acthar Gel is a prescription medication used to treat symptoms of sarcoidosis.
FOR PATIENTS WITH SYMPTOMS OF SARCOIDOSIS Treatment Journal H.P. Acthar Gel is a prescription medication used to treat symptoms of sarcoidosis. IMPORTANT SAFETY INFORMATION Who should NOT take Acthar?
More information(sunitinib malate) for Kidney Cancer
Sutent (sunitinib malate) for Kidney Cancer Sutent is a medication used to treat adult patients with kidney cancer that has been surgically removed and at high risk of recurrence, or advanced kidney cancer
More informationClopidogrel apollo
Clopidogrel apollo +9191 46 950 950 Clopidogrel apollo +9191 46 950 950 Clopidogrel CAS Number : 113665-84-2 Molecular Weight : 321.82 g/mol Molecular Formula : C16H16ClNO2S Systematic (IUPAC) : methyl
More informationPatient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA?
Patient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA? ARNUITY ELLIPTA is an inhaled corticosteroid (ICS) medicine
More informationPATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid)
PATIENT INFORMATION LEAFLET Nu-Seals 75 aspirin (acetylsalicylic acid) Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you
More informationNEXIUM INTRAVENOUS esomeprazole sodium
NEXIUM INTRAVENOUS esomeprazole sodium Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about NEXIUM Intravenous (IV). It does not contain
More informationMedication information for patients and families
Medication information for patients and families What is Imuran? Imuran is a medication that reduces the activity of the immune system. This type of medication is called an immunosuppressive. Imuran comes
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr SYLVANT pronounced SILL-vant siltuximab for injection Read this carefully before you start taking SYLVANT and each
More informationEloxatin Oxaliplatin concentrated solution for injection
Eloxatin Oxaliplatin concentrated solution for injection Consumer Medicine Information Please read this leaflet before you are given this medicine. What is in this leaflet This leaflet answers some common
More informationFor the Patient: USMAVNIV
For the Patient: USMAVNIV Other Names: Treatment of Unresectable or Metastatic Melanoma Using Nivolumab U = Undesignated (requires special approval) SM = Skin and Melanoma AV = AdVanced NIV = NIVolumab
More informationBefore you take CORTATE. When you must not take it
Cortate(R) Cortisone acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information that is known about
More informationyour breathing problems worsen quickly. you use your rescue inhaler, but it does not relieve your breathing problems.
MEDICATION GUIDE ADVAIR DISKUS [ad vair disk us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation What is the most important information I should know about ADVAIR DISKUS?
More informationFor the Patient: ULUAVPMB
For the Patient: ULUAVPMB Other Names: Treatment of Advanced Non-Small Cell Lung Cancer Using Pembrolizumab U = Undesignated (requires special approval) LU = LUng AV = AdVanced PMB = PeMBrolizumab ABOUT
More informationMEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:
MEDICATION GUIDE Lamotrigine (lam-oh-try-jeen) Tablets USP Rx only What is the most important information I should know about lamotrigine tablets? 1. Lamotrigine tablets may cause a serious skin rash that
More informationPATIENT INFORMATION LEAFLET
N-CORT 0.055% Nasal Spray For nasal use. PATIENT INFORMATION LEAFLET Active substance(s): Triamcinolone acetonide (w/w%) 0.055 Excipient(s): Benzalkonium chloride 50%, sodium hydroxide, hydrochloric acid,
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr AVAMYS fluticasone furoate nasal spray FOR NASAL USE ONLY This leaflet is part III of a three-part "Product Monograph" published when AVAMYS was approved for sale in Canada
More informationHERNOVIR 200 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationATORIS 10, 20, 40 mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER ATORIS 10, 20, 40 mg film-coated tablets ATORVASTATIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationCilazapril apollo
Cilazapril apollo +9191 46 950 950 Cilazapril apollo +9191 46 950 950 Cilazapril CAS Number : 92077-78-6 Molecular Weight : 417.49 g/mol Molecular Formula : C22H31N3O5 Systematic (IUPAC) : (1S,9S)-9-{[(2S)-1-ethoxy-1-
More informationPackage leaflet: Information for the patient. Icsori 250 microgram per actuation pressurised inhalation, suspension. fluticasone propionate
Package leaflet: Information for the patient Icsori 125 microgram per actuation pressurised inhalation, suspension Icsori 250 microgram per actuation pressurised inhalation, suspension fluticasone propionate
More informationTAFEN NASAL 50mcg nasal spray, suspension
PACKAGE LEAFLET: INFORMATION FOR THE USER TAFEN NASAL 50mcg nasal spray, suspension BUDESONIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationMETHYLDOPA 250 mg Film-coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationRamipril apollo Ramipril apollo
Ramipril apollo +9191 46 950 950 Ramipril apollo +9191 46 950 950 Ramipril CAS Number : 87333-19-5 Molecular Formula : C23H32N2O5 Molecular Weight : 416.51 g/mol Systematic (IUPAC) : (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] Mepolizumab for Injection Read this carefully before you start taking NUCALA and each time you
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide
PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need
More informationNilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.
For the Patient: Other names: TASIGNA (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. Blood tests may be taken regularly during treatment.
More informationAll medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you.
New Zealand Consumer Medicine Information MABTHERA SC Rituximab 1400 mg solution for subcutaneous injection for non-hodgkin s Lymphoma and 1600mg solution for subcutaneous injection for chronic lymphocytic
More informationImportant safety information to minimise the risk of immune-related adverse reactions
Your Guide to KEYTRUDA (pembrolizumab) Important safety information to minimise the risk of immune-related adverse reactions Information for Patients This medicine is subject to additional monitoring.
More informationMedicines Information
Oxford Children s Hospital Paediatric Gastroenterology Department Steroids Information for patients and parents Medicines Information This information leaflet answers common questions parents and patients
More informationEscitalopram apollo
Escitalopram apollo +9191 46 950 950 Escitalopram apollo +9191 46 950 950 Escitalopram CAS Number : 128196-01-0 Molecular Formula : C20H21FN2O Molecular Weight : 324.39 g/mol Systematic (IUPAC) : (1S)-1-[3-
More informationSummary of the risk management plan (RMP) for Budesonide/Formoterol Teva (budesonide / formoterol)
EMA/639304/2014 Summary of the risk management plan (RMP) for Budesonide/Formoterol Teva (budesonide / formoterol) This is a summary of the risk management plan (RMP) for Budesonide/Formoterol Teva, which
More informationSummary of the risk management plan (RMP) for DuoResp Spiromax (budesonide / formoterol)
EMA/126654/2014 Summary of the risk management plan (RMP) for DuoResp Spiromax (budesonide / formoterol) This is a summary of the risk management plan (RMP) for DuoResp Spiromax, which details the measures
More informationOtezla (apremilast) film coated tablets
New Zealand Consumer Medicine Information Otezla (apremilast) film coated tablets WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Otezla. It does not contain all the available
More informationOXIS TURBUHALER Formoterol fumarate dihydrate for inhalation
OXIS TURBUHALER Formoterol fumarate dihydrate for inhalation Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Oxis Turbuhaler. It does not contain
More informationDiscussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor
Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor TECENTRIQ DISCUSSION SUPPORT What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: A type of bladder
More informationDULERA [dew-lair-ah] 100 mcg/5 mcg DULERA 200 mcg/5 mcg What is DULERA? DULERA is not used to relieve sudden breathing problems Do not use DULERA:
PATIENT INFORMATION DULERA [dew-lair-ah] 100 mcg/5 mcg (mometasone furoate 100 mcg and formoterol fumarate dihydrate 5 mcg) Inhalation Aerosol DULERA 200 mcg/5 mcg (mometasone furoate 200 mcg and formoterol
More informationRANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationNORVASC 5 mg and 10 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationAgreed Core Safety Profile for Budesonide nasal spray suspension and Budesonide nasal powder
CSP Drug Budesonide Substance Date 13 Oct 2011 rev 11Nov Supersedes 18 Aug 2011 Agreed Core Safety Profile for DK/H/PSUR/0041/001 TABLE OF CONTENTS PAGE TITLE PAGE... 1 TABLE OF CONTENTS... 2 Introduction...
More informationFor the Patient: USMAVPEM
For the Patient: USMAVPEM Other Names: Treatment of Unresectable or Metastatic Melanoma Using Pembrolizumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced PEM = Pembrolizumab
More informationSummary of the risk management plan (RMP) for Vylaer Spiromax (budesonide / formoterol)
EMA/675937/2014 Summary of the risk management plan (RMP) for Vylaer Spiromax (budesonide / formoterol) This is a summary of the risk management plan (RMP) for Vylaer Spiromax, which details the measures
More informationPatient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR
Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any
More informationFDA APPROVED MEDICATION GUIDE
FDA APPROVED MEDICATION GUIDE Valproic Acid Oral Solution Read this Medication Guide before you start taking valproic acid and each time you get a refill. There may be new information. This information
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationTRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.
TRIPROLIDINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains triprolidine. This leaflet is intended to provide information on the active ingredient
More informationFor the Patient: Ponatinib Other names: ICLUSIG
For the Patient: Other names: ICLUSIG (poe na' ti nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. The tablet contains lactose. Tell your doctor if you
More informationCore Safety Profile. Pharmaceutical form(s)/strength: Dry Powder Inhaler, Nebuliser Suspension, pressurised Metered Dose Inhaler (pmdi)
Core Safety Profile Active substance: Budesonide Pharmaceutical form(s)/strength: Dry Powder Inhaler, Nebuliser Suspension, pressurised Metered Dose Inhaler (pmdi) P - RMS: DK/H/PSUR/0041/001 Date of FAR:
More informationMEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules
MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules Read this Medication Guide before you start taking Valproic Acid Capsules and each time you get a refill. There may be new information. This information
More informationTrastuzumab and Lapatinib
PATIENT EDUCATION patienteducation.osumc.edu What is Trastuzumab (tras-too-zoo-mab) and how does it work? Trastuzumab is a type of targeted cancer therapy called a monoclonal antibody. Another name for
More informationOXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION OEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation This leaflet is part III of a three-part Product Monograph published when
More informationPackage leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)
Package leaflet: Information for the patient Loratadine 10 mg Tablets (loratadine) Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationImodium 1 mg/5 ml oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Imodium 1 mg/5 ml oral solution Loperamide hydrochloride Imodium is a registered trademark Read all of this leaflet carefully before you start using this medicine
More information